Best Practice & Research Clinical Rheumatology
Volume 20, Issue 6 , Pages 1159-1179 , December 2006

Rheumatologic complications of HIV infection

  • John D. Reveille, MD (Professor and Director)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +1 713 500 6900; Fax: +1 713 500 0523.

References 

  1. Merson MH. 1884 The HIV-AIDS Pandemic at 25 – The Global Response. The New England Journal of Medicine. 2006;354:2414–2417
  2. http://www.who.int/hiv/pub/epidemiology/epiupdate2005/en/index.html
  3. Dalakas MC, Pereshkpour GH, Gravell M, Sever JL. Polymyositis associated with the AIDS retrovirus. JAMA. 1986;256:2381–2383
  4. Yanker BA, Skolnik PR, Shoukimas GM, et al. Cerebral granulomatous angiitis associated with the isolation of the human-T lymphotropic virus type III from the central nervous system. Annals of Neurology. 1986;20:362–364
  5. Winchester R, Bernstein DH, Fischer HD, et al. The co-occurrence of Reiter's syndrome and acquired immunodeficiency. Annals of Internal Medicine. 1987;106:19–26
  6. Ulirsch RC, Jaffe ES. Sjögren's syndrome-like illness associated with the acquired immunodeficiency syndrome-related complex. Human pathology. 1987;18:1063–1068
  7. Berman A, Espinoza LR, Diaz JD, et al. Rheumatic manifestations of human immunodeficiency virus infection. The American Journal of Medicine. 1988;85:59–64
  8. Calabrese LH. Autoimmune manifestations of human immunodeficiency virus (HIV) infection. Clinics in Laboratory Medicine. 1988;8:269–279
  9. Munoz-Fernandez S, Cardenal A, Balsa A, et al. Rheumatic manifestations in 556 patients with human immunodeficiency virus infection. Seminars in Arthritis and Rheumatism. 1991;21:30–39
  10. Buskila D, Gladmann DD, Langevitz P, et al. Rheumatologic manifestations of infection with the human immunodeficiency virus (HIV). Clinical and Experimental Rheumatology. 1990;8:567–573
  11. Pouchot J, Simonpoli AM, Bortolotti V, et al. Painful articular sydrome and human immunodeficiency virus infection. Archives of Internal Medicine. 1992;152:646–649
  12. Rynes RI, Goldenberg DL, DiGiacomo R, et al. Acquired immunodeficiency syndrome-associated arthritis. The American Journal of Medicine. 1988;84:810–816
  13. Berman A, Cahn P, Perez H, et al. Human immunodeficiency virus infection associated arthritis: clinical characteristics. The Journal of Rheumatology. 1999;26:1158–1162
  14. Reveille JD. The changing spectrum of rheumatic disease in human immunodeficiency virus infection. Seminars in Arthritis and Rheumatism. 2000;30:147–166
  15. Mody GM, Parke F, Reveille JD. Articular manifestations of human immunodeficiency virus infection. Best Practice and Research. Clinical Rheumatology. 2003;17:265–287
  16. Ornstein MH, Sperber K. The anti-inflammatory and antiviral effects of hydroxychloroquine in two patients with acquired immunodeficiency syndrome and active inflammatory arthritis. Arthritis and Rheumatism. 1996;39:157–161
  17. Winchester R, Brancato L, Itescu S, et al. Implications from the occurrence of Reiter's syndrome and related disorders in association with advanced HIV infection. Scandinavian Journal of Rheumatology. 1988;74(supplement):89–93
  18. Clark MR, Solinger AM, Hochberg MC. Human immunodeficiency virus infection is not associated with Reiter's syndrome. Data from three large cohort studies. Rheumatic Diseases Clinics of North America. 1992;18:267–276
  19. Reveille JD, Conant MA, Duvic M. HIV-associated psoriasis, psoriatic arthritis and Reiter's syndrome: A disease continuum?. Arthritis and Rheumatism. 1990;33:1574–1578
  20. Bourinbaiar AS, Lee-Huang S. The non-steroidal anti-inflammatory drug, indomethacin, as an inhibitor of HIV replication. FEBS Letters. 1995;360:85–88
  21. Youssef PP, Bertouch W, Jones PD. Successful treatment of human immunodeficiency virus-associated Reiter's syndrome with sulfasalazine. Arthritis and Rheumatism. 1992;35:723–724
  22. Disla E, Rhim HR, Reddy A, Taranta A. Improvement in CD4 lymphocyte count in HIV-Reiter's syndrome after treatment with sulfasalazine. The Journal of Rheumatology. 1993;21:662–664
  23. Masson C, Chennebault JM, Leclech C. Is HIV infection a contraindication to the use of methotrexate in psoriatic arthritis?. The Journal of Rheumatology. 1995;22:2191
  24. Sperber K, Kalb TH, Stecher VJ, et al. Inhibition of human immunodeficiency virus type I replication by hydroxychloroquine in T cells and monocytes. AIDS Research and Human Retroviruses. 1993;9:91–98
  25. Louthrenoo W. Successful treatment of severe Reiter's syndrome associated with human immunodeficiency virus infection with etretinate. Report of 2 cases. The Journal of Rheumatology. 1993;20:1243–1246
  26. Gaylis N. Infliximab in the treatment of an HIV positive patient with Reiter's syndrome. The Journal of Rheumatology. 2003;30:407–411
  27. Duvic M, Johnson TM, Rapini RP. Acquired immunodeficiency syndrome-associated psoriasis and Reiter's syndrome. Archives of Dermatology. 1987;123:1622–1632
  28. Espinoza LR, Berman AVFB. Psoriatic arthritis and acquired immunodeficiency syndrome. Arthritis and Rheumatism. 1988;31:1034–1040
  29. Duvic M, Crane MM, Conant M, et al. Zidovudine improves psoriasis in human immunodeficiency-positive males. Archives of Dermatology. 1994;130:447–451
  30. Tourne L, Durez P, Van Vooren JP, et al. Alleviation of HIV-associated psoriasis and psoriatic arthritis with cyclosporine. Journal of the American Academy of Dermatology. 1997;37:501–502
  31. Aboulafia DM, Bundow D, Wilske K, Ochs UI. Etanercept for the treatment of human immunodeficiency virus-associated psoriatic arthritis. Mayo Clinic Proceedings. 2000;75:1093–1098
  32. McGonagle D, Reade S, Marzo-Ortega H, et al. Human immunodeficiency virus associated spondyloarthropathy: pathogenic insights based on imaging findings and response to highly active antiretroviral treatment. Annals of the Rheumatic Diseases. 2001;60:696–698
  33. Wrzolek MA, Sher JH, Kozlowski PB, Rao C. Skeletal muscle pathology in AIDS: An autopsy study. Muscle and Nerve. 1990;13:508–515
  34. Manfredi R, Motta R, Patrono D, et al. A prospective case-control survey of laboratory markers of skeletal muscle damage during HIV disease and antiretroviral therapy. AIDS. 2002;16:1969–1971
  35. Johnson RW, Williams FM, Kazi S, et al. Human immunodeficiency virus-associated polymyositis: A longitudinal study of outcome. Arthritis and Rheumatism. 2003;49:172–178
  36. Buskila D, Gladman D, Langevitz P, et al. Fibromyalgia in human immunodeficiency virus infection. The Journal of Rheumatology. 1990;17:1202–1206
  37. Simms RW, Zerbini CAF, Ferrante N, et al. Boston City Hospital Clinical AIDS Team: Fibromyalgia syndrome in patients infected with human immunodeficiency virus. The American Journal of Medicine. 1992;92:368–374
  38. Simpson DM, Bender AM, Farraye J, et al. Human immunodeficiency virus wasting syndrome may represent a treatable myopathy. Neurology. 1990;40:535–538
  39. Gonzales MF, Olney RK, So YT, et al. Subacute structural myopathy associated with human immunodeficiency virus. Archives of Neurology. 1988;45:585–587
  40. Miro O, Pedrol E, Cebrian M, et al. Skeletal muscle studies in patients with HIV-related wasting syndrome. Journal of the Neurological Sciences. 1997;150:153–159
  41. Illa I, Nath A, Dalakas M. Immunocytochemical and virological characteristics of HIV-associated inflammatory myopathies: Similarities with seronegative polymyositis. Annals of Neurology. 1991;29:474–481
  42. Simpson DM, Bender AN. Human immunodeficiency virus-associated myopathy: Analysis of 11 patients. Annals of Neurology. 1988;24:79–84
  43. Leon-Monzon M, Lamperth L, Dalakas M. Search for HIV proviral DNA and amplified sequences in the muscle biopsies of patients with HIV polymyositis. Muscle and Nerve. 1992;16:408–413
  44. Seidman R, Peress NS, Nuovo GJ. In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids in skeletal muscle in patients with myopathy. Modern Pathology. 1994;7:369–375
  45. Cupler EJ, Leon-Monzon M, Miller J, et al. Inclusion-body myositis in HIV-1 and HTLV-1 infected patients. Brain. 1996;119:1887–1893
  46. Schreiner B, Voss J, Wischhusen J, et al. Expression of toll-like receptors by human muscle cells in vitro and in vivo: TLR3 is highly expressed in inflammatory and HIV myopathies, mediates IL-8 release and up-regulation of NKG2D-ligands. The FASEB Journal. 2006;20:118–120
  47. Dalakas MC, Pezeshkpour GH, Flaherty M. Progressive nemaline (rod) myopathy associated with HIV infection. The New England Journal of Medicine. 1987;317:1602–1603
  48. Feinberg DM, Spiro AJ, Weidenheim KM. Distinct light microscopic changes in human immunodeficiency virus-associated nemaline myopathy. Neurology. 1998;50:529–531
  49. Ansaloni L, Acaye GL, Re M. High HIV seroprevalence among patients with pyomyositis in northern Uganda. Tropical Medicine and International Health. 1996;1:210–215
  50. Jellis J. Orthopaedic surgery and HIV disease in Africa. International Orthopaedics. 1996;20:253–256
  51. Gherardi R, Baudrimont M, Lionnet F, et al. Skeletal muscle toxoplasmosis in patients with acquired immunodeficiency syndrome: A clinical and pathological study. Annals of Neurology. 1992;32:535–542
  52. Wiley CA, Nerenberg M, Cros D, Soto-Aguilar MC. HTLV-I polymyositis in a patient also infected with the human immunodeficiency virus. The New England Journal of Medicine. 1989;320:992–995
  53. Itescu S, Brancato LJ, Buxbaum J, et al. A diffuse infiltrative CD8 lymphocytosis syndrome in human immunodeficiency virus (HIV) infection: A host immune response associated with HLA-DR5. Annals of Internal Medicine. 1990;112:3–10
  54. Williams FM, Cohen PR, Jumshyd J, Reveille JD. Prevalence of the diffuse infiltrative lymphocytosis syndrome among human immunodeficiency virus type 1-positive outpatients. Arthritis and Rheumatism. 1998;41:863–868
  55. Kordossis T, Paikos S, Aroni K, et al. Prevalence of Sjögren's-like syndrome in a cohort of HIV-1-positive patients: descriptive pathology and immunopathology. British Journal of Rheumatology. 1998;37:691–695
  56. Basu D, Williams FM, Ahn CW, Reveille JD. The changing spectrum of diffuse infiltrative lymphocytosis syndrome. Arthritis and Rheumatism. 2006;54:466–472
  57. Itescu S, Dalton J, Zhang HZ, Winchester R. Tissue infiltration in a CD8 lymphocytosis syndrome associated with human immunodeficiency virus-1 infection has the phenotypic appearance of an antigenically driven response. The Journal of Clinical Investigation. 1993;91:2216
  58. Kazi S, Cohen PR, Williams F, et al. The diffuse infiltrative lymphocytosis syndrome: Clinical and immunogenetic features in 35 patients. AIDS. 1996;10:385–391
  59. Schiodt M, Dodd CL, Greenspan D, et al. Natural history of HIV-associated salivary gland disease. Oral Surgery, Oral Medicine, and Oral Pathology. 1992;74:326–331
  60. Itescu S, Winchester R. Diffuse infiltrative lymphocytosis syndrome: A disorder occurring in human immunodeficiency virus-1 infection that may present as a sicca syndrome. Rheumatic diseases clinics of North America. 1992;18:683–697
  61. Barrett S, Goh J, Coughlan B, et al. The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection. Gut. 2001;49:423–430
  62. Rosenberg ZS, Joffe SA, Itescu S. Spectrum of salivary gland disease in HIV-infected patients: Characterization with Ga-67 citrate imaging. Radiology. 1992;184:761–764
  63. Holliday RA, Cohen WA, Schinella RA, et al. Benign lymphoepithelial parotid cysts and hyperplastic cervical adenopathy in AIDS-risk patients: A new CT appearance. Radiology. 1988;168:439–441
  64. Craven DE, Duncan RA, Stram JR, et al. Response of lymphoepithelial parotid cysts to antiretroviral treatment in HIV-infected adults. Annals of Internal Medicine. 1998;128:455–459
  65. Gherardi R, Belec L, Mhiri C, et al. The spectrum of vasculitis in human immunodeficiency virus-infected patients. A clinicopathologic evaluation. Arthritis and Rheumatism. 1993;36:1164–1174
  66. Buskila D, Gladman DD, Gilmore J, Salit IE. Behçet's disease in a patient with immunodeficiency virus infection. Annals of the Rheumatic Diseases. 1991;50:115–116
  67. Chetty R, Batitang S, Nair R. Large artery vasculopathy in HIV-positive patients: another vasculitic enigma. Human pathology. 2000;31:374–379
  68. Bayrou O, Phlippoteau C, Artigou C, et al. Adult Kawasaki syndrome associated with HIV infection and anticardiolipin antibodies. Journal of the American Academy of Dermatology. 1993;29:663–664
  69. Brannagan T. Retroviral-associated vasculitis of the nervous system. Neurologic Clinics. 1997;15:927–944
  70. Bradley WG, Verma A. Painful vasculitic neuropathy in HIV-1 infection: Relief of pain with prednisone therapy. Neurology. 1996;47:1446–1451
  71. Vassilopoulos D, Chalasani P, Jurado RL, et al. Musculoskeletal infections in patients with human immunodeficiency virus infection. Medicine (Baltimore). 1997;76:284–294
  72. Hirsch R, Miller SM, Kazi S, et al. Human immunodeficiency virus–associated atypical mycobacterial skeletal infarctions. Seminars in Arthritis and Rheumatism. 1996;25:347–356
  73. Edelstein H, McCabe R. Candida albicans septic arthritis and osteomyelitis of the sternoclavicular joint in a patient with human immunodeficiency virus infection. The Journal of Rheumatology. 1991;18:110–111
  74. Heller HM, Fuhrer J. Disseminated sporotrichosis in patients with AIDS: Case report and review of the literature. AIDS. 1991;5:1243–1246
  75. Bijlsma JS, Derksen RW, Huber-Bruning O, Borleffs JC. Does AIDS ‘cure’ rheumatoid arthritis. Annals of the Rheumatic Diseases. 1988;47:350–351
  76. Ornstein MH, Kerr LD, Spiera H. A re-examination of the relationship between active rheumatoid arthritis and the acquired immunodeficiency syndrome. Arthritis and Rheumatism. 1995;38:1701–1706
  77. Fernandez-Miranda C, Rubio R, Pulido F. Development of acquired immune deficiency syndrome in a patient with systemic lupus erythematosus. The Journal of Rheumatology. 1996;23:1308
  78. Wegrzyn J, Livrozet JM, Touraine JL, Miossec P. Rheumatoid arthritis after 9 years of human immunodeficiency virus infection: possible contribution of tritherapy. The Journal of Rheumatology. 2002;29:2232–2234
  79. Diri E, Lipsky PE, Berggren RE. Emergence of systemic lupus erythematosus after initiation of highly active antiretroviral therapy for human immunodeficiency virus infection. The Journal of Rheumatology. 2000;27:2711–2714
  80. Kaye BR. Rheumatologic manifestations of infection with human immunodeficiency virus (HIV). Annals of Internal Medicine. 1989;111:158–167
  81. Canoso RT, Zon LI, Groopman JE. Anticardiolipin antibodies associated with HTLV-III infection. British Journal of Haematology. 1987;65:495–498
  82. Fabris P, Tositti G, Giordani MT, et al. Prevalence and clinical significance of circulating cryoglobulins in HIV-positive patients with and without co-infection with hepatitis C virus. Journal of Medical Virology. 2003;69:339–343
  83. Klaassen RJ, Goldschmeding R, Dolman KM, et al. Anti-neutrophil cytoplasmic autoantibodies in patients with symptomatic HIV infection. Clinical and Experimental Immunology. 1992;87:24–30
  84. Blanche P, Taelman H, Saraux A, et al. Acute arthritis and human immunodeficiency virus infection in Rwanda. The Journal of Rheumatology. 1993;20:2123–2127
  85. Stein CM, Davis P. Arthritis associated with HIV infection in Zimbabwe. The Journal of Rheumatology. 1996;23:506–511
  86. Bileckot R, A Mouaya, Makuwa M. Prevalence and clinical presentations of arthritis in HIV-positive patients seen at a rheumatology department in Congo-Brazzaville. Revue du Rhumatisme (English ed.). 1997;64:60–63
  87. Njobvu P, McGill P. Psoriatic arthritis and human immunodeficiency virus infection in Zambia. The Journal of Rheumatology. 2000;27:1699–1702
  88. Chinniah K, Mody GM, Bhimma R, Adhikari M. Arthritis in association with human immunodeficiency virus infection in Black African children: causal or coincidental?. Rheumatology (Oxford). 2005;44:915–920
  89. Ntsiba H, Lamini N. Is inflammatory joint disease in HIV-infected patients a form of spondyloarthropathy?. Joint Bone Spine. 2004;71:300–302
  90. Lopez-Larrea C, Njobvu PD, Gonzalez S, et al. The HLA-B*5703 allele confers susceptibility to the development of spondylarthropathies in Zambian human immunodeficiency virus-infected patients with slow progression to acquired immunodeficiency syndrome. Arthritis and Rheumatism. 2005;52:275–279
  91. McArthur CP, Africa CW, Castellani WJ, et al. Salivary gland disease in HIV/AIDS and primary Sjogren's syndrome: analysis of collagen I distribution and histopathology in American and African patients. Journal of Oral Pathology and Medicine. 2003;32:544–551
  92. Otedo AE, Oyoo GO, Obondi JO, Otieno CF. Vasculitis in HIV: report of eight cases. East African Medical Journal. 2005;82:656–659
  93. Bessen LJ, Greene JB, Louie E, et al. Severe polymyositis-like syndrome associated with zidovudine therapy of AIDS and ARC. The New England Journal of Medicine. 1988;318:708
  94. Florence E, Schrooten W, Verdonck K, et al. Rheumatological complications associated with the use of indinavir and other protease inhibitors. Annals of the Rheumatic Diseases. 2002;61:82–84
  95. Olive A, Salavert A, Manriquez M, et al. Parotid lipomatosis in HIV positive patients: a new clinical disorder associated with protease inhibitors. Annals of the Rheumatic Diseases. 1998;57:749
  96. Glesby MJ, Hoover DR, Vaamonde CM. Osteonecrosis in patients infected with human immunodeficiency virus: a case-control study. The Journal of Infectious Diseases. 2001;184:519–523
  97. Mastroianni A. Emergence of Sjögren's syndrome in AIDS patients during highly active antiretroviral therapy. AIDS. 2004;18:1349–1352
  98. Calza L, Manfredi R, Colangeli V, et al. Polymyositis associated with HIV infection during immune restoration induced by highly active anti-retroviral therapy. Clinical and Experimental Rheumatology. 2004;22:651–652
  99. Calabrese LH, Kirchner E, Shrestha R. Rheumatic complications of human immunodeficiency virus infection in the era of highly active antiretroviral therapy: emergence of a new syndrome of immune reconstitution and changing patterns of disease. Seminars in Arthritis and Rheumatism. 2005;35:166–174
  100. Marquez J, Restrepo CS, Candia L, et al. Human immunodeficiency virus-associated rheumatic disorders in the HAART era. The Journal of Rheumatology. 2004;31:741–746
  101. Panayiotakopoulos GD, Aroni K, Kyriaki D, et al. Paucity of Sjögren's like syndrome in a cohort of HIV-1 positive patients in the HAART era. Part II. Rheumatology. 2003;42:1164–1167

PII: S1521-6942(06)00119-7

doi: 10.1016/j.berh.2006.08.015

Best Practice & Research Clinical Rheumatology
Volume 20, Issue 6 , Pages 1159-1179 , December 2006

Article Tools

* Image Usage & Resolution